Cargando…

Neuroprotective agents in the management of glaucoma

Glaucoma is an optic neuropathy, specifically a neurodegenerative disease characterized by loss of retinal ganglion cells (RGCs) and their axons. The pathogenesis of RGC loss in glaucoma remains incompletely understood and a broad range of possible mechanisms have been implicated. Clinical evidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nucci, C., Martucci, A., Giannini, C., Morrone, L. A., Bagetta, G., Mancino, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944652/ https://www.ncbi.nlm.nih.gov/pubmed/29472700 http://dx.doi.org/10.1038/s41433-018-0050-2

Ejemplares similares

Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020)

Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain
por: Mancino, Raffaele, et al.
Publicado: (2018)

Evidence on neuroprotective properties of coenzyme Q10 in the treatment of glaucoma
por: Martucci, Alessio, et al.
Publicado: (2019)

The promise of neuroprotection by dietary restriction in glaucoma
por: Russo, Rossella, et al.
Publicado: (2021)

Spectral Domain Optical Coherence Tomography Assessment of Macular and Optic Nerve Alterations in Patients with Glaucoma and Correlation with Visual Field Index
por: Martucci, Alessio, et al.
Publicado: (2018)

Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
por: Martucci, Alessio, et al.
Publicado: (2022)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
por: Mancino, R, et al.
Publicado: (2018)

Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma☆
por: Fang, Jiahua, et al.
Publicado: (2012)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

Neuroprotection by leptin in a rat model of permanent cerebral ischemia: effects on STAT3 phosphorylation in discrete cells of the brain
por: Amantea, D, et al.
Publicado: (2011)

Intravitreal injection of forskolin, homotaurine, and L-carnosine affords neuroprotection to retinal ganglion cells following retinal ischemic injury
por: Russo, Rossella, et al.
Publicado: (2015)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015)

Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)

Association Between Alzheimer's Disease and Glaucoma: A Study Based on Heidelberg Retinal Tomography and Frequency Doubling Technology Perimetry
por: Cesareo, Massimo, et al.
Publicado: (2015)

MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease
por: Martucci, Alessio, et al.
Publicado: (2023)

Macular ganglion cells alteration in a patient with left homonymous hemianopia subsequent to surgical excision of an arteriovenous malformation
por: Martucci, Alessio, et al.
Publicado: (2018)

Editorial: New perspectives in glaucoma pathophysiology, diagnosis, and treatment
por: Martucci, Alessio, et al.
Publicado: (2023)

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma
por: Tribble, James R., et al.
Publicado: (2021)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Current perspective of neuroprotection and glaucoma
por: Tian, Kailin, et al.
Publicado: (2015)

Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis
por: Scuteri, Damiana, et al.
Publicado: (2023)

Primary Open Angle Glaucoma Is Associated With Functional Brain Network Reorganization
por: Minosse, Silvia, et al.
Publicado: (2019)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Galanopoulos, Anna, et al.
Publicado: (2009)

Glaucomatous Optic Neuropathy Management: the Role of Neuroprotective Agents
por: L. Shahsuvaryan, Marianne
Publicado: (2013)

Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo
por: Russo, R, et al.
Publicado: (2011)

Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU -
por: Panahi, Yunes, et al.
Publicado: (2018)

New perspectives of immunomodulation and neuroprotection in glaucoma
por: Skopiński, Piotr, et al.
Publicado: (2021)

Opioids Resistance in Chronic Pain Management
por: Morrone, Luigi A., et al.
Publicado: (2017)

Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance
por: Kuo, Che-Yuan, et al.
Publicado: (2022)

Innovative IOP-Independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma
por: Tsai, James C.
Publicado: (2020)

Retinal and Choroidal Vasculature in Patients with Marfan Syndrome
por: Di Marino, Matteo, et al.
Publicado: (2020)

Neuroprotection in Glaucoma: Old and New Promising Treatments
por: Rusciano, Dario, et al.
Publicado: (2017)

Quinones as Neuroprotective Agents
por: Cores, Ángel, et al.
Publicado: (2023)

Neuroprotective Effect of a Nutritional Supplement Containing Spearmint Extract, Forskolin, Homotaurine and Group B Vitamins in a Mouse Model of Transient Ocular Hypertension
por: Satriano, Andrea, et al.
Publicado: (2023)

Nutraceutical Antioxidants as Novel Neuroprotective Agents
por: Kelsey, Natalie A., et al.
Publicado: (2010)

Neuroprotective Agents with Therapeutic Potential for COVID-19
por: Zaa, César A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nmb78roq6c22bpjldp0ntvsjeb